The study, published in The Lancet Regional Health - Europe journal, is based on nationwide registry data from the Public Health Agency of Sweden, the National Board of Health and Welfare, and Statistics Sweden.
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden.
Lancet study revealed that in comparison to unvaccinated people, people who got jabbed with AstraZeneca and Moderna COVID vaccines were less prone to infection.
The study conducted among 700,000 individuals in Sweden showed that people who received the first dose of the Oxford-AstraZeneca Covid-19 vaccine followed by a shot of the mRNA vaccine exhibited a lower risk of infection.
London, October 18
People who received a first dose of the Oxford-AstraZeneca Covid vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses